Inovio Pharmaceuticals, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for INO, updated each market day.
INO AI Sentiment
AI predicts Inovio Pharmaceuticals, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
Sector
Exchange
Market Cap
$85,671,553
Cap Tier
Employees
112
Headquarters
PLYMOUTH MEETING, PA
Listed Since
Dec. 8, 1998
Website
INO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
INO Volatility
Inovio Pharmaceuticals, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
